Assignee
ORPHAGEN PHARMACEUTICALS INC
US·1 granted patent·3 pending applications·0 citations·filing 2017–2022
Top patents by PatentIndex Score
4 records- 0155US2018258133A1Modulators of retinoid-related orphan receptor gammaORPHAGEN PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0252US2017267712A1Modulators of retinoid-related orphan receptor gammaORPHAGEN PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0342US2024208982A1Pyrazolopyrimidinone compoundsORPHAGEN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0441US12492177B2RAR-α compounds for inflammatory disease and male contraceptionORPHAGEN PHARMACEUTICALS INC·Filed 2020·Granted Dec 9, 2025·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when ORPHAGEN PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →